OLBA HEALTHCARE (2689) Q1 2025 earnings summary

Executive summary

• Net sales rose 5.6% year-over-year to ¥29,044 million for the quarter ended September 30, 2024.

• Operating profit increased 11.3% year-over-year to ¥279 million, while ordinary profit grew 13.8% to ¥284 million.

• Profit attributable to owners of parent remained stable at ¥168 million, nearly unchanged from the prior year.

• Comprehensive income improved 11.4% year-over-year to ¥160 million.

Financial highlights

• Gross profit increased to ¥3,264 million from ¥3,052 million year-over-year.

• Operating margin for the quarter was approximately 1.0%.

• Basic earnings per share rose slightly to ¥28.42 from ¥27.90 year-over-year.

• Total assets as of September 30, 2024, were ¥43,523 million, up from ¥43,237 million at June 30, 2024.

• Equity ratio declined to 25.3% from 26.3% at the previous quarter-end.

Outlook and guidance

• Full-year net sales forecasted at ¥123,726 million, up 4.4% year-over-year.

• Full-year operating profit projected at ¥2,270 million, up 0.4% year-over-year.

• Profit attributable to owners of parent expected to decrease 2.4% to ¥1,465 million.

• Basic earnings per share for the full year forecasted at ¥247.65.

• Dividend forecast maintained at ¥80 per share for the year.